Autosomal dominant mutations in FH are associated with hereditary leiomyomatosis and renal cell cancer, indicating that FH functions as a tumor suppressor (Launonen et al., 2001; Tomlinson et al., 2002). This evidence concerns the gene FH and renal cell adenocarcinoma.